Background
- Despite the increased prevalence in actionable driver-negative (DN) NSCLC, the role ofTP53mutations in this subtype is not fully explored.
- We characterize the association ofTP53mutations with the molecular and immune landscapes, as well as outcomes, in in the context of histologic subtypes.